| Rationale for the advancement of PI3K pathway inhibitors for personalized chordoma therapy NL Michmerhuizen, JH Owen, ME Heft Neal, JE Mann, E Leonard, ... Journal of Neuro-oncology 147, 25-35, 2020 | 11 | 2020 |
| Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma NL Michmerhuizen, ML Ludwig, AC Birkeland, S Nimmagadda, J Zhai, ... Head & neck 44 (5), 1192-1205, 2022 | 5 | 2022 |
| Mutant HRas Signaling and Rationale for Use of Farnesyltransferase Inhibitors in Head and Neck Squamous Cell Carcinoma J Wang, D Al-Majid, JC Brenner, JD Smith Targeted Oncology, 1-13, 2023 | 3 | 2023 |
| Combined Pik3ca-H1047R and loss-of-function Notch1 alleles decrease survival time in a 4-nitroquinoline N-oxide-driven head and neck squamous cell carcinoma model NL Michmerhuizen, C Heenan, J Wang, E Leonard, E Bellile, ... Oral oncology 126, 105770, 2022 | 1 | 2022 |
| Long read sequencing identifies complex structural variant landscape and recurrent TERT rearrangements in mucoepidermoid carcinoma E Gensterblum-Miller, A Bhangale, D Al Majid, VM Pienkowski, ... Oral Oncology 159, 107108, 2024 | | 2024 |
| Multi-kinase compensation rescues EGFR knockout in a cell line model of Head and Neck Squamous Cell Carcinoma ML Ludwig, NL Michmerhuizen, J Wang, AC Birkeland, B Karaj, ... Archives of Oral Biology, 105822, 2023 | | 2023 |
| Integrated Molecular Profiling as an Approach to Identify PI3K Inhibitor Resistance Mechanisms NL Michmerhuizen, J Wang, JC Brenner Molecular Pharmacology, 2020 | | 2020 |
